Somewhat contrasts the findings of others reporting that the protective effects of metformin on the development of NAFLD were associated with a protection from the loss of occludin and ZO-1 in ileum and colon14, in the present study effects on tight junction proteins were found in proximal small intestine. The gene discussed is OCLN; the disease is metabolic dysfunction-associated steatotic liver disease.